BioLineRx Ltd.
BLRX · Pharmaceutical Preparations
Latest available SEC filing: 3 ·
Latest disclosures
-
Yan Shaoyu: Form 3
Insider disclosure · Filed · Report period 18 Mar 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001498403 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- BLRX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2 Hamaayan Street, Modi In Technology Park, Modi In, ISRAEL
- Incorporated in
- Israel
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields